Is Aclaris Therapeutics Inc (ACRS) a Poor Choice in the Healthcare Sector?

Aclaris Therapeutics Inc (ACRS) is around the bottom of the Healthcare sector according to InvestorsObserver. ACRS received an overall rating of 0, which means that it scores higher than 0% of stocks. Additionally, Aclaris Therapeutics Inc scored a 25 in the Healthcare sector, ranking it higher than 25% of stocks in that sector.

ACRS has an Overall Score of 0. Find out what this means to you and get the rest of the rankings on ACRS!

See Full ACRS Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 0 means the stock is more attractive than 0 percent of stocks. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Aclaris Therapeutics Inc Stock Today?

Aclaris Therapeutics Inc (ACRS) stock is up 3.03% while the S&P 500 is lower by -0.11% as of 9:43 AM on Friday, Nov 17. ACRS is higher by $0.03 from the previous closing price of $0.89 on volume of 208,594 shares. Over the past year the S&P 500 has gained 14.10% while ACRS is lower by -94.94%. ACRS lost -$1.67 per share the over the last 12 months. Click Here to get the full Stock Report for Aclaris Therapeutics Inc stock.